The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons

The lack of early diagnostic biomarkers for schizophrenia greatly limits treatment options that deliver therapeutic agents to affected cells at a timely manner. While previous schizophrenia biomarker research has identified various biological signals that are correlated with certain diseases, their...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Davin Lee, Jinsoo Seo, Hae chan Jeong, Hyosang Lee, Sung Bae Lee
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/8f0e77b326464418bbc9c9772a40590e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f0e77b326464418bbc9c9772a40590e
record_format dspace
spelling oai:doaj.org-article:8f0e77b326464418bbc9c9772a40590e2021-11-12T13:17:42ZThe Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons1662-509910.3389/fnmol.2021.756613https://doaj.org/article/8f0e77b326464418bbc9c9772a40590e2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnmol.2021.756613/fullhttps://doaj.org/toc/1662-5099The lack of early diagnostic biomarkers for schizophrenia greatly limits treatment options that deliver therapeutic agents to affected cells at a timely manner. While previous schizophrenia biomarker research has identified various biological signals that are correlated with certain diseases, their reliability and practicality as an early diagnostic tool remains unclear. In this article, we discuss the use of atypical epigenetic and/or consequent transcriptional alterations (ETAs) as biomarkers of early-stage schizophrenia. Furthermore, we review the viability of discovering and applying these biomarkers through the use of cutting-edge technologies such as human induced pluripotent stem cell (iPSC)-derived neurons, brain models, and single-cell level analyses.Davin LeeJinsoo SeoHae chan JeongHyosang LeeSung Bae LeeFrontiers Media S.A.articleschizophreniaiPSCorganoidepigenetic alterationtranscriptional alterationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Molecular Neuroscience, Vol 14 (2021)
institution DOAJ
collection DOAJ
language EN
topic schizophrenia
iPSC
organoid
epigenetic alteration
transcriptional alteration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle schizophrenia
iPSC
organoid
epigenetic alteration
transcriptional alteration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Davin Lee
Jinsoo Seo
Hae chan Jeong
Hyosang Lee
Sung Bae Lee
The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
description The lack of early diagnostic biomarkers for schizophrenia greatly limits treatment options that deliver therapeutic agents to affected cells at a timely manner. While previous schizophrenia biomarker research has identified various biological signals that are correlated with certain diseases, their reliability and practicality as an early diagnostic tool remains unclear. In this article, we discuss the use of atypical epigenetic and/or consequent transcriptional alterations (ETAs) as biomarkers of early-stage schizophrenia. Furthermore, we review the viability of discovering and applying these biomarkers through the use of cutting-edge technologies such as human induced pluripotent stem cell (iPSC)-derived neurons, brain models, and single-cell level analyses.
format article
author Davin Lee
Jinsoo Seo
Hae chan Jeong
Hyosang Lee
Sung Bae Lee
author_facet Davin Lee
Jinsoo Seo
Hae chan Jeong
Hyosang Lee
Sung Bae Lee
author_sort Davin Lee
title The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
title_short The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
title_full The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
title_fullStr The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
title_full_unstemmed The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons
title_sort perspectives of early diagnosis of schizophrenia through the detection of epigenomics-based biomarkers in ipsc-derived neurons
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/8f0e77b326464418bbc9c9772a40590e
work_keys_str_mv AT davinlee theperspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT jinsooseo theperspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT haechanjeong theperspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT hyosanglee theperspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT sungbaelee theperspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT davinlee perspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT jinsooseo perspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT haechanjeong perspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT hyosanglee perspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
AT sungbaelee perspectivesofearlydiagnosisofschizophreniathroughthedetectionofepigenomicsbasedbiomarkersinipscderivedneurons
_version_ 1718430448024027136